The mechanism by which IGF-1 and its signaling pathways protect against NAFLD have been found to involve a variety of biological functions, such as improving insulin sensitivity, decreasing ROS production, and inducing senescence of hepatic stellate cells [99–101]. Here, IGF1 is linked to metabolic dysfunction-associated steatotic liver disease.